12:00 AM
Sep 24, 2012
 |  BC Week In Review  |  Company News  |  Deals

Kyowa Hakko Kirin, Otsuka Pharmaceutical deal

The companies terminated a deal under which Kyowa acquired development and commercialization rights to Busulfex busulfan from Otsuka. As part of the termination, which is effective March 31, 2013,...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >